Genesis Healthcare Inc. (NYSE:GEN) traded up 1.9% during mid-day trading on Monday . The company traded as high as $2.26 and last traded at $2.15, with a volume of 92,943 shares changing hands. The stock had previously closed at $2.11.

A number of equities research analysts have recently issued reports on the stock. Stephens cut shares of Genesis Healthcare from an “overweight” rating to a “hold” rating in a report on Wednesday, May 11th. Royal Bank Of Canada decreased their price target on shares of Genesis Healthcare from $5.00 to $3.00 and set an “outperform” rating on the stock in a research note on Monday, May 16th. Finally, Bank of America Corp. lowered shares of Genesis Healthcare from a “neutral” rating to an “underperform” rating in a research note on Monday, May 16th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $4.40.

The stock has a 50-day moving average price of $1.78 and a 200 day moving average price of $2.13. The firm’s market cap is $331.68 million.

Genesis Healthcare (NYSE:GEN) last released its quarterly earnings results on Monday, May 9th. The company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by $0.04. During the same quarter in the prior year, the firm earned $0.07 earnings per share. The company had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.43 billion. Genesis Healthcare’s quarterly revenue was up 9.6% compared to the same quarter last year. Equities research analysts expect that Genesis Healthcare Inc. will post ($0.01) earnings per share for the current year.

Genesis Healthcare, Inc, formerly Skilled Healthcare Group, Inc, is a holding company that provides post-acute care. The Company operates through three segments: long-term care (LTC), which includes the operation of skilled nursing facilities and assisted living facilities; therapy services, which includes its integrated and third-party rehabilitation therapy services, and hospice and home health services, which includes its hospice and home health businesses.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.